or Try an Advanced Search...

    Akseli Hemminki Stocks List

    Symbol Grade Name % Change
    CLDI D Calidi Biotherapeutics, Inc. -0.47
    REPL B Replimune Group, Inc. 35.11
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Cancer Oncolytic Virus Solid Tumors Virotherapy Cancer Immunotherapy Cancer Treatment Cell Biology Cell Therapy Clinical Medicine Experimental Cancer Treatments Glioma Immune System Immunotherapy Immunotherapy Products Medicine Metastatic Disease Rp1 Stem Cell Transgene Sa

    Related ETFs - A few ETFs which own one or more of the above listed Akseli Hemminki stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 1.56
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 0.99
    MEDX F Horizon Kinetics Medical ETF 0.98
    PTH C Invesco DWA Healthcare Momentum ETF 0.74
    SBIO C ALPS Medical Breakthroughs ETF 0.5
    View all Akseli Hemminki ETFs...
    Compare ETFs
    Compare BBC to PTH Compare CNCR to SBIO Compare PTH to SBIO

        Akseli Hemminki Stocks Recent News

        Date Stock Title
        Nov 22 REPL S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
        Nov 22 REPL Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug
        Nov 22 REPL Replimune climbs after updates on lead drug
        Nov 22 REPL Replimune's stock surges 19% after-hours on FDA BLA submission
        Nov 21 REPL Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Cancer Oncolytic Virus Solid Tumors Virotherapy Cancer Immunotherapy Cancer Treatment Cell Biology Cell Therapy Clinical Medicine Experimental Cancer Treatments Glioma Immune System Immunotherapy Immunotherapy Products Medicine Metastatic Disease Rp1 Stem Cell Transgene Sa
        Akseli Hemminki

        Akseli Hemminki (1973-07-27) July 27, 1973 (Helsinki) is a Finnish specialist in Oncology and Radiotherapy, Professor of Oncology and founder of two biotechnology companies.

        More about Akseli Hemminki
        Browse All Tags